CN Stock MarketDetailed Quotes

603998 Hunan Fangsheng Pharmaceutical

Watchlist

10.31
-0.11-1.06%

Trading Jan 2 13:57 CST

4.53BMarket Cap16.58P/E (TTM)

Hunan Fangsheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hunan Fangsheng Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	437.71M	--
		+21.69%
EPS	--	0.20	--
		--

Analyst Rating

Strong Buy

Jan 2, 2025

Hunan Fangsheng Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.131B	--
--	2024/FY	-- / 1.831B	--
--	2023/FY	1.629B / 1.802B	--
Mar 31, 2023	2022/FY	1.792B / 1.877B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.131B--

--2024/FY-- / 1.831B--

--2023/FY1.629B / 1.802B--

Mar 31, 20232022/FY1.792B / 1.877B--

--------

Unlock Free Earnings Estimates

Open Account

Hunan Fangsheng Pharmaceutical Earnings Reports

Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Report for the Third Quarter of 2024

Oct 28, 2024 12:00 ET

Fangsheng Pharmaceutical Report for the Third Quarter of 2024

Oct 28, 2024 12:00 ET

Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024

Oct 28, 2024 12:00 ET

Fangsheng Pharmaceutical 2024 Semi-Annual Report

Aug 28, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Geovis Insighter Technology

Xdc Industries(Shenzhen)Limited

Shanghai DOBE Cultural & Creative Industry Development

300947

18.74 +18.08%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 2, 2025

Strong Buy

Strong Buy
93.75%
Buy
6.25%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

The Concept of Three Children